Rituximab for rheumatoid arthritis - Wikidata - wikimedia - TriplyDB

Rituximab for rheumatoid arthritis

Rituximab for rheumatoid arthritis

http://www.wikidata.org/entity/Q24242554

about

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis Subcutaneous or intramuscular methotrexate for rheumatoid arthritis Interventions for periodontal disease in people with rheumatoid arthritis Tocilizumab for rheumatoid arthritis Certolizumab pegol (CDP870) for rheumatoid arthritis in adults Tocilizumab for rheumatoid arthritis Biologics for rheumatoid arthritis: an overview of Cochrane reviews Golimumab for rheumatoid arthritis Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

P2860

Q24185797-6327FA6A-DCB7-4F38-B907-A5AE12BAEEA4 Q24187565-A7836078-128E-4692-9BDE-92528AE3F7DE Q24200961-2FF52855-52D9-4CC1-914C-9F02A05A66FD Q24234126-25F5EEB5-3D4D-403D-9FF7-F7CCE355DDBF Q24236701-E6CE6431-EF03-40D1-9256-B5CB71315503 Q24239949-68FDA97D-20F4-4A76-94FB-1E2528B1484A Q24240731-A70D93C8-7874-4D14-AE53-C7E79B568FF9 Q24240895-553A6CA1-F783-48FE-839B-33E873C2CB20 Q30235341-03E949B2-574C-4C13-A566-F42512770E92

P2860

Rituximab for rheumatoid arthritis

http://www.wikidata.org/entity/Q24242554

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Rituximab for rheumatoid arthritis

@ast

Rituximab for rheumatoid arthritis

@en

Rituximab for rheumatoid arthritis

@en-gb

Rituximab for rheumatoid arthritis

@nl

type

label

Rituximab for rheumatoid arthritis

@ast

Rituximab for rheumatoid arthritis

@en

Rituximab for rheumatoid arthritis

@en-gb

Rituximab for rheumatoid arthritis

@nl

prefLabel

Rituximab for rheumatoid arthritis

@ast

Rituximab for rheumatoid arthritis

@en

Rituximab for rheumatoid arthritis

@en-gb

Rituximab for rheumatoid arthritis

@nl

P1433

Q24242554-25AC2182-5321-49D3-B2AB-B68F60B4E6BA

P1476

Q24242554-E0ECBEAB-FD21-457F-8452-5CEBEF725D4F

P2093

Q24242554-969E7993-B0A3-4841-A8B2-FA449AE1EBEA

Q24242554-F134E319-F818-422A-954E-E0C9EF90A33B

Q24242554-F4003C46-ED28-40FF-AA60-A1FA583A04A1

P2860

Q24242554-22F3741A-9D01-4E9E-A56E-11E08EB2412C

Q24242554-2FAA5E90-5BCF-4890-858F-6BF3960BA2CE

Q24242554-31D9AB2B-EB54-4574-8680-28A9D1F7512F

Q24242554-35D69281-263A-4C1F-9451-975380BB6EF4

Q24242554-4B7F554F-ACFF-4258-A22B-2EC26AB6DA5A

Q24242554-7F818DD6-0207-4C79-B5B5-B5A47ECD4D70

Q24242554-8DBF001D-F0BA-4862-8BC9-C61A2C99FC05

Q24242554-A12FD9E2-D316-4C5F-AA93-F7B92EF8ABE6

Q24242554-B0B90805-729E-4C1E-8978-EBE68746F7F9

Q24242554-CEA6AFBE-71E4-4D74-968C-063A785440CB

P31

Q24242554-D55765F0-24FC-4517-8896-4DDA3FAA88EE

P356

Q24242554-56D353A2-A6C4-4839-BE45-9342D9A7CA92

P50

Q24242554-105D9770-6BD3-484D-9B46-582721FA3474

P577

Q24242554-D2D80B60-1CB4-4C98-A640-0838EF6AC88C

P356

14651858.CD007356

P1433

Cochrane Database of Systematic Reviews

P1476

Rituximab for rheumatoid arthritis

@en

P2093

Lynda McGahan

http://www.w3.org/2001/XMLSchema#string

Maria E Suarez-Almazor

http://www.w3.org/2001/XMLSchema#string

Matxalen Amezaga

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets.

New drugs for rheumatoid arthritis.

B cell non-Hodgkin's lymphoma: rituximab safety experience.

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies.

P31

scholarly article

P356

10.1002/14651858.CD007356

http://www.w3.org/2001/XMLSchema#string

P50

Maria Angeles Lopez-Olivo

P577

2008-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime